High-content screening of drug-induced mitochondrial impairment in hepatic cells: effects of statins

Abstract

A frequent mechanism for drug-induced liver injury (DILI) is mitochondrial impairment, and early evaluation of new drugs for their potential to cause mitochondrial dysfunction is becoming an important task for drug development. To this end, we designed a high-content screening assay to study mitochondrial-induced hepatotoxicity in HepG2 cells in detail. Simultaneous assessment of mitochondrial mass and cell viability in cells exposed for 24 h to compounds provides preliminary information on the mitochondrial- or nonmitochondrial-related hepatotoxic potential of compounds. To fully address the mechanisms implicated in mitochondrial impairment, prelethal changes in mitochondrial superoxide production, mitochondrial membrane potential, mitochondrial permeability transition, intracellular calcium concentration and apoptotic cell death were studied in cells incubated for 1 h with compounds. The assay correctly classified a set of well-known mitochondrial toxicants and negative controls and revealed high sensitivity for the detection of mitochondrial DILI and the establishment of different mitochondrial toxicity risks (low to high). This procedure was used for analysing the potential mitochondrial impairment of six statins to determine their clinical risk. All the tested statins produced mitochondrial impairment, although they showed different levels of toxicity (low-medium toxicity risk). The results suggest that this cell-based assay is a promising in vitro approach to predict the potential of drug candidates to induce mitochondrial-associated hepatotoxicity.

New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease

“…The HCS imaging station Scan from Olympus was used to analyze neutral lipid content and MMP, by using the specific fluorescent probes BODIPY 493/503 and TMRM, respectively (Molecular Probes, Invitrogen, Barcelona; Tolosa et al, 2015). …”

The Effects of Melatonin on Elevated Liver Enzymes during Statin Treatment

“…It is suggested that statins cause damage to mitochondrial membranes which leads to the leakage of aminotransferases [47, 48]. Statin lipophilicity may play an important role.…”

The Changing Paradigm in Preclinical Toxicology: in vitro and in silico Methods in Liver Toxicity Evaluations

“…In addition to high-content screening, where several parameters are measured as simultaneous readouts in single cells (Gasparri, 2009), high-content imaging will play an important complimentary role in systems biology approaches (van Vliet et al, 2014). High-content platforms have been already used for the screening of compounds (Bale et al, 2014;Sirenko et al, 2014;Tolosa et al, 2014).…”